Bioactive substance accumulation and septic complications in a burn trauma patient: Effect of perioperative blood transfusion?

Burns

Volumn 23, Issue 1, 1997, Pages 59-63

  Nielsen, Hans Jørgen ^a,b,d   Reimert, C M ^c   Dybkjaer E ^a   Roed, J ^a   Alsbjorn B ^d  

^a Dept of Surgical Gastroenterology ^*  (Denmark)

^b Immunological Laboratory   (Denmark)

^c Rigshospitalet   (Denmark)

^d HVIDOVRE HOSPITAL   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

EOSINOPHIL CATIONIC PROTEIN; FRESH FROZEN PLASMA; HISTAMINE; INTERLEUKIN 6; MYELOPEROXIDASE;

ADULT; ARTICLE; BLOOD STORAGE; BLOOD TRANSFUSION; BURN; CASE REPORT; CLINICAL FEATURE; ENZYME LINKED IMMUNOSORBENT ASSAY; ERYTHROCYTE TRANSFUSION; GRAM NEGATIVE INFECTION; HUMAN; MALE; PSEUDOMONAS AERUGINOSA; RADIOIMMUNOASSAY; SEPSIS; SKIN GRAFT; THROMBOCYTE TRANSFUSION; URINALYSIS;

ADULT; ANTI-BACTERIAL AGENTS; BACTEREMIA; BLOOD PROTEINS; BLOOD TRANSFUSION; BURNS, CHEMICAL; COMBINED MODALITY THERAPY; DRUG THERAPY, COMBINATION; ENZYME-LINKED IMMUNOSORBENT ASSAY; EOSINOPHIL GRANULE PROTEINS; EOSINOPHIL-DERIVED NEUROTOXIN; HISTAMINE; HUMANS; INFLAMMATION MEDIATORS; INTERLEUKIN-6; MALE; PEROXIDASE; PSEUDOMONAS INFECTIONS; RADIOIMMUNOASSAY; RIBONUCLEASES; SKIN TRANSPLANTATION; SURGICAL WOUND INFECTION;

EID: 0031028085     PISSN: 03054179     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0305-4179(96)00059-9     Document Type: Article

References (39)

1. Nielsen HJ. Detrimental effects of perioperative blood transfusion. Br J Surg 1995; 82: 582-587.
2. Isbister JP. Adverse reactions to plasma and plasma products. Anaesth Intens Care 1993; 21: 31-38.
3. Heddle NM, Klama L, Singer J et al. The role of plasma from platelet concentrates in transfusion reactions. N Engl J Med 1994; 331: 635-638.
4. Bordin JO, Heddle NM, Blajchman MA. Biologic effects of leucocytes present in transfused cellular blood components. Blood 1994; 84: 1703-1721.
5. Nicholls MD. Transfusion: morbidity and mortality. Anaesth Intens Care 1993; 21: 15-19.
6. Malouf M, Glanville AR. Blood transfusion related adult respiratory distress syndrome. Anaesth Intens Care 1993; 21: 44-49.
7. Jeter EK, Spivey MA. Noninfectious complications of blood transfusion. Hematol Oncol Clin North Am 1995; 9: 187-204.
8. Nielsen HJ, Hammer JH, Moesgaard F, Kehlet H. Comparison of the effects of SAGM and whole-blood transfusions on postoperative suppression of delayed hypersensitivity. Can J Surg 1991; 34: 146-150.
9. Gafter U, Kalechman D, Sredni B. Induction of a subpopulation of suppressor cells by a single blood transfusion. Kidney Int 1992; 41: 143-148.
10. Gianotti L, Pyles T, Alexander JW, Fukushima R, Babcock GF. Identification of the blood component responsible for increased susceptibility to gut-derived infection. Transfusion 1993; 33: 458-465.
11. Blumberg N, Heal JM. Effects of transfusion on immune function, cancer recurrence and infection. Arch Pathol Lab Med 1994; 118: 371-379.
12. Frewin DB, Jonsson JR, Frewin CR et al. Influence of blood storage time and plasma levels on the pattern of transfusion reactions. Vox Sang 1989; 56: 243-246.
13. Hoh H, Umpleby H, Cooper A, Taylor I. Recurrence of colorectal cancer and perioperative blood transfusion. Is blood storage time important? Dis Colon Rectum 1990; 33: 127-130.
14. Marik PE, Sibbald WJ. Effect of stored-blood transfusion on oxygen delivery in patients with sepsis. JAMA 1993; 269: 3024-3029.
15. Nielsen HJ, Edvardsen L, Vangsgaard K, Dybkjær E, Skov PS. Time-dependent histamine release from stored human blood products. Br J Surg 1996; 83: 259-262.
16. Nielsen HJ, Reimert CM, Pedersen AN et al. Time-dependent, spontaneous release of leucocyte and platelet derived bioactive substances from stored human blood. Transfusion 1996 (in press).
17. Edvardsen L, Nielsen HJ, Pedersen AN et al. Time-dependent release of leucocyte and platelet derived bio-active substances in stored standard platelet concentrates. Eur J Hematol 1996; 57: 185-187.
18. Nielsen HJ, Reimert CM, Dybkjær E, et al. Leucocyte derived bioactive substances in fresh frozen plasma. Eur J Hematol 1996 (in press).
19. Hermann K, Frank G, Ring J. Contamination of heparin by histamine: measurement and characterization by high-performance liquid chromatography and radioimmunoassay. Allergy 1994; 49: 569-572.
20. Reimert CM, Venge P, Kharazmi A, Bendtzen K. Detection of eosinophil cationic protein (ECP) by an enzyme-linked immuno-sorbent assay. J Immunol Methods 1991; 138: 285-293.
21. Reimert CM, Minuva U, Kharazmi A, Bendtzen K. Eosinophil protein X/eosinophil derived neurotoxin (EPX/EDN): detection by enzyme-linked immuno-sorbent assay and purification from normal human urine. J Immunol Methods 1991; 141: 97-104.
22. Graves TA, Cioffi MG, Mason AD, McManus WF, Pruitt BA. Relationship of transfusion and infection in a burn trauma population. J Trauma 1989; 29: 948-954.
23. Edna TH, Bjerkeset T. Association between blood transfusion and infection in injured patients. J Trauma 1992; 33: 659-661.
24. Agarwal N, Murphy JG, Cayten G, Stahl WM. Blood transfusion increases the risk of infection after trauma. Arch Surg 1993; 128: 171-177.
25. Houbiers JGA, Brand A, van der Watering LMG et al. Randomised controlled trial comparing transfusion of leucocyte-depleted or buffy-coat-depleted blood in surgery for colorectal cancer. Lancet 1994; 344: 573-578.
26. Frewin DB, Jonsson JR, Head RJ, Russell WJ, Beal RW. Histamine levels in stored human blood. Transfusion 1984; 24: 502-504.
27. Babior BM. Oxidants from phagocytes: agents of defense and destruction. Blood 1984; 64: 959-966.
28. Pearce FL. Biological effects of histamine: an overview. Agents Actions 1991; 33: 4-7.
29. Weller PF. The Immunobiology of eosinophils. N Engl J Med 1991; 324: 1110-1118.
30. Nielsen HJ. The effect of histamine type-2 receptor antagonists on post-traumatic immune competence. Dan Med Bull 1995; 42: 162-174.
31. Fredens K, Dybdal H, Dahl R, Baandrup U. Extracellular deposit of the cationic proteins ECP and EPX in tissue infiltrations of eosinophils related to tissue damage. APMIS 1988; 96: 711-719.
32. Wakefield CH, Carey PD, Foulds S, Monson JP, Guillou PJ. Polymorphonuclear leucocyte activation. An early marker of the postsurgical sepsis response. Arch Surg 1993; 128: 390-395.
33. Kurose I, Granger DN. Evidence implicating xantine oxidase and neutrophils in reperfusion-induced microvascular dysfunction. Ann NY Acad Sci 1994; 723: 158-179.
34. Kishimoto T. The biology of interleukin-6. Blood 1989; 74: 1-10.
35. Stouthard JM, Romijn JA, van der Poll T et al. Endocrinologic and metabolic effects of interleukin-6 in humans. Am J Physiol 1995; 268: E813-819.
36. Damas P, Ledoux D, Nys M et al. Cytokine serum level during severe sepsis in humans. IL-6 as a marker of severity. Ann Surg 1992; 215: 356-362.
37. Baue AE. The horror autotoxicus and multiple-organ failure. Arch Surg 1992; 127: 1451-1462.
38. Reimert CM, Poulsen LK, Bindslev-Jensen C, Kharazmi A, Bendtzen K. Measurement of eosinophil cationic protein (ECP) and eosinophil protein X/eosinophil derived neurotoxin (EPX/EDN).
39. Humbert JR, Fermin CD, Windsor EL. Early damage of granulocytes during storage. Semin Hematol 1991; 28 (suppl 5): 10-13.